Atlas Trials

Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors

Clinical trial NCT00253422 · COMPLETED

Trial details

NCT number
NCT00253422
Sponsor
Institute of Cancer Research, United Kingdom
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2004-03-26
Primary completion
2022-11-28
Enrollment
698

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.